Braun-Bostich & Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
Braun-Bostich & Associates's THC Position: Q1 2022 in Review
Braun-Bostich & Associates sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 3,357 shares — an estimated $258K sold.
Braun-Bostich & Associates first reported a position in THC in Q4 2021 and held it in 1 quarter. The position peaked at $258K in Q4 2021. 404 funds tracked by Wall St. Rank hold THC as of Q1 2022.
- Braun-Bostich & Associates reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
- Braun-Bostich & Associates sold 3,357 Tenet Healthcare shares in Q1 2022, an estimated $258K.
- Braun-Bostich & Associates first reported a position in Tenet Healthcare in Q4 2021 and held it in 1 quarter.
- Braun-Bostich & Associates's Tenet Healthcare position peaked at $258K in Q4 2021.
- 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.
Based on Braun-Bostich & Associates's 13F filing for Q1 2022, filed 13 May 2022.